Diagnostic accuracy of procalcitonin as a marker of neonatal sepsis
DOI:
https://doi.org/10.18203/2349-3291.ijcp20231499Keywords:
Neonatal sepsis, Serum procalcitonin, C-reactive protein, Blood culture, Positive predictive value, Negative predictive valueAbstract
Background: Sepsis is defined as “life-threatening organ dysfunction, caused by a dysregulated host response to infection”. Neonatal sepsis is the most common cause of morbidity and mortality in the neonatal period. Early diagnosis of neonatal sepsis is difficult. Therefore, this study was conducted with the objective to assess the diagnostic accuracy of procalcitonin as marker of neonatal sepsis and its comparison with C-reactive protein.
Methods: The present study was a hospital-based descriptive comparative study. A total of 59 neonates were enrolled. All suspected neonates for the sepsis admitted to NICU were enrolled in study on the basis of inclusion and exclusion criteria. A detailed clinical examination was done. Blood sample was collected for procalcitonin, C-reactive protein and blood culture. Statistical analysis was performed.
Results: In our study diagnostic accuracy of procalcitonin in diagnosis of neonatal sepsis was sensitivity (88.46%), specificity (87.88%), positive predictive value (85.19%), negative predictive value (90.63%) and diagnostic accuracy (88.14%). Diagnostic value of C-reactive protein in diagnosis of neonatal sepsis was sensitivity (88.46%), specificity (69.70%), positive predictive value (69.70%), negative predictive value (88.46%) and diagnostic accuracy (77.97%). Diagnostic accuracy of procalcitonin is maximum followed by C-reactive protein.
Conclusions: In our study all patient with gram negative organism were procalcitonin positive whereas 50% Staphylococcus aureus were procalcitonin positive and in candida positive cases out of 6 cases, 5 (83.3%) were procalcitonin positive.
References
Kőszegi T. Advances in the diagnosis of sepsis. eJIFCC. 2017;28(2):99-103.
Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38(5):483-93.
Behrman Re, Kliegman R, Jensen HB Barbara S. Infections of the neonatal infant. In: editors. Behrman: Nelson Textbook of Pediatrics. Philadelphia: WB Saunders CO. 2008;42(5):794-811.
Vasantha AR, Kutty SN, Theodore RB. Neonatal sepsis: Aetiological agents and risk factors. J Acad Clin Microbiol. 2017;19(1):36-41.
Iroh Tam P, Bendel C. Diagnostics for neonatal sepsis: Current approaches and future directions. Pediatric Res. 2017;82(4):574-83.
Rashwan N, Hassan M, Mohey El-Deen Z, Ahmed A. Validity of biomarkers in screening for neonatal sepsis (single centerhospital based study). Pediatric Neonatol. 2019;60(2):149-55.
Pérez Solís D, López Sastre JB, Coto Cotallo GD, Diéguez Junquera MA, Deschamps Mosquera EM, Crespo Hernández M. Procalcitonin for the diagnosis of nosocomial neonatal sepsis. An Pediatr (Barc). 2006;64(4):349-53.
Levy M, Evans L, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;44(6):925-8.
Naher BS, Mannan MA, Noor K, Shahidullah M. Role of serum Procalcitonin and C-reactive protein in the diagnosis of neonatal sepsis. Bangladesh Med Res Council Bulletin. 2011;37(2):40-6.
Vijayan A, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R, et al. Procalcitonin: A promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.
Rogic D, Juros GF, Petrik J, Vrancic AL. Advances and pitfalls in using laboratory biomarkers for the diagnosis and management of sepsis. eJIFCC. 2017;28(2):114-21.
Trasy D, Molnar Z. Procalcitonin–assisted antibiotic strategy in sepsis. eJIFCC. 2017;28(2):104-13.
Hasan F, Khan SA, Maharoof MK, Muhammed N. Role of Procalcitonin in early diagnosis of neonatal sepsis. Int J Contemp Pediatrics. 2017;4(2):383-9.
Shrestha RK, Rai SK, Mandhal PK. Bacteriological study of neo natal sepsis and antibiotic susceptibility pattern of isolates in Kathmandu, Nepal. Nepal Med Coll J. 2013;15(1):71-3.
Viswanathan R, Singh AK, Ghosh C, Dasgupta S, Mukherje S, Basu S. Profile of Neonatal Septicaemia at a District-level Sick Newborn Care Unit. J Health Popul Nutr. 2012;30(1):41-8.
Kar SS, Dube R, Mahapatro S, Kar SS. The role of clinical signs in the diagnosis of late onset neonatal sepsis and formation of clinical score. Indian J Clin Prac. 2003;23(23):654-60.
Koizumi Y, Sakanashi D, Ohno T, Nakamura A, Yamada A, Shibata Y, et al. Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics. J Microbiol Immunol Infect. 2021;54(6):1028-37.
Wang H, Yin F, Shen DX, Zhang YJ, Luo YP, Liu CJ, et al. Predictive value of procalcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for Procalcitonin. J Int Med Res. 2013;41(5):1671-81.
Cortegiani A, Misseri G, Ippolito M, Bassetti M, Giarratano A, Martin-Loeches I, et al. Procalcitonin levels in candidemia versus bacteremia: a systematic review. Crit Care. 2019;23(1):190.
World Health Organization. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses, 2nd edition. World Health Organization. 2013. Available at: https://apps.who.int/iris/handle/10665/81170. Accessed on 24 March 2023.
Jeergal NA, Rizwan-u-zama NA, Malagi N, Farooqui F, Ukkali SB, Naganoor R, Thobbi AN. Procalcitonin as a marker of neonatal sepsis. Al Ameen J Med Sci. 2016;9(1):70-3.
Pontrelli G, De Crescenzo F, Buzzetti R, Jenkner A, Balduzzi S, Calò Carducci F, et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. BMC Infect Dis. 2017;17(1):302.
